Titre:
  • Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer.
Auteur:Bedard, Philippe L; Singhal, Sandeep K; Ignatiadis, Michail; Bradbury, Ian; Haibe-Kains, Benjamin; Desmedt, Christine; Loi, Sherene; Evans, Dean B; Michiels, Stefan; Dixon, J Michael; Miller, William R; Piccart-Gebhart, Martine; Sotiriou, Christos
Informations sur la publication:Endocrine-related cancer, 18, 6, page (721-730)
Statut de publication:Publié, 2011-10
Sujet CREF:Cancérologie
Note générale:Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1351-0088
info:doi/10.1530/ERC-11-0180
info:pii/ERC-11-0180
info:scp/84855916374
info:pmid/21984694